Literature DB >> 6180082

Increased expression of beta 2-microglobulin and histocompatibility antigens on human lymphoid cells induced by interferon.

M Hokland, I Heron, K Berg.   

Abstract

Normal human peripheral blood lymphocytes were incubated in the presence of different concentrations of interferon for various incubation periods. Subsequently, the amount of beta 2-Microglobulin and HLA-A, B and C surface antigens was estimated by means of quantitative immunofluorescence (flow cytofluorometry) and by a radioimmunoassay for beta 2-Microglobulin. It was found that the amounts of these MHC antigens increased in a dose and time-dependent way after interferon treatment. Furthermore, the influence of different temperatures on this IFN-induced increase in beta 2-Microglobulin was gradually enhanced after incubation at 37 degrees C to 39 degrees C incubation mostly suppressed the beta 2-Microglobulin increase observed at 39 degrees C. The total amount of membrane associated beta 2-Microglobulin was estimated by a radioimmunoassay. After interferon treatment a beta 2-Microglobulin increase was observed ranging from 39% to 122% in different experiments. It is shown that interferon is the substance responsible for the effects on lymphocytes reported here, because completely pure interferon-proteins had the same activity as has been shown for partially purified interferon preparations.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6180082     DOI: 10.1089/jir.1981.1.483

Source DB:  PubMed          Journal:  J Interferon Res        ISSN: 0197-8357


  8 in total

Review 1.  Regulation of cell growth by interferon.

Authors:  M Shearer; J Taylor-Papadimitriou
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

Review 2.  IFN-induced modulation of histocompatibility antigens on human cells. Background, mechanisms and perspectives.

Authors:  M Hokland; P Basse; J Justesen; P Hokland
Journal:  Cancer Metastasis Rev       Date:  1988-11       Impact factor: 9.264

3.  Enhanced expression in vivo of HLA-ABC antigens and beta 2-microglobulin on human lymphoid cells induced by human interferon-alpha in patients with lung cancer. Enhanced expression of class I major histocompatibility antigens prior to treatment.

Authors:  M H Nissen; T Plesner; J K Larsen; B K Olesen; P Ernst
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

4.  Serum beta 2-microglobulin and C reactive protein concentrations in viral infections.

Authors:  E H Cooper; M A Forbes; M H Hambling
Journal:  J Clin Pathol       Date:  1984-10       Impact factor: 3.411

5.  [Follow-up in HIV-infected homosexual males with lymphadenopathy syndrome].

Authors:  T Harrer; K Messing; U Bienzle; E Meyer; J Giedl; J R Kalden
Journal:  Klin Wochenschr       Date:  1987-09-15

6.  Interferon-beta in patients with low-grade astrocytomas--a phase I study.

Authors:  U Bogdahn; B Fleischer; J Hilfenhaus; H J Röthig; P Krauseneck; H G Mertens; H Przuntek
Journal:  J Neurooncol       Date:  1985       Impact factor: 4.130

Review 7.  Protective immunity to liver-stage malaria.

Authors:  Lauren E Holz; Daniel Fernandez-Ruiz; William R Heath
Journal:  Clin Transl Immunology       Date:  2016-10-21

8.  Recombinant DNA human interferon alpha 2 in advanced breast cancer: a phase 2 trial.

Authors:  N Padmanabhan; F R Balkwill; J G Bodmer; R D Rubens
Journal:  Br J Cancer       Date:  1985-01       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.